Close Window

Digital Look Email A Friend

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

Published by Michele Maatouk on 10th October 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

URL: http://www.digitallook.com/dl/news/story/29691972/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.